Systematic Review on the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior Uveitis

2010/07/25 by Esperanza Pato, Santiago Muñoz-Fernández, Santiago Muñoz‐Fernández +7 · 2 citations
Medicine · #Adalimumab #Anterior uveitis #Arthritis #Autoimmune and Inflammatory Disorders Research #Daclizumab #Dermatology #Disease #Etanercept #Immunology #Infliximab #Intermediate uveitis #Internal medicine #Macular edema #Medicine #Ocular Diseases and Behçet’s Syndrome #Ophthalmology #Otitis Media and Relapsing Polychondritis #Psoriatic arthritis #Retinal vasculitis #Rheumatoid arthritis #Secukinumab #Transplantation #Uveitis #Vasculitis #Visual acuity

paper · doi:10.1016/j.semarthrit.2010.05.008

openalex publication_date 2010/07/25 · crossref created 2010/07/25 · crossref issued 2011/02/01 · crossref published 2011/02/01 · crossref published-print 2011/02/01 · crossref deposited 2025/09/24 · openalex created_date 2025/10/10 · crossref indexed 2026/01/26 · openalex updated_date 2026/07/28

Citations

• A randomized, placebo‐controlled, double‐masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis
• Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop

Cited by

• Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults
• Uveitis [wikipedia]